PubMed Health⌕ Search

Biomedical subjects

D Bakshi

Publications and source records attributed to D Bakshi.

3 recordsLinked to original sources

Selective neonatal BCG vaccination.

AIMS: To assess the implementation of the "Selective Neonatal BCG Immunisation Policy", and to study the causes of non-compliance, or failure of uptake of BCG immunization. METHODS: The Birth Register data were used to generate a list of babies born in the catchment area of Basildon and Thurrock NHS Trust between 1 January 2001 and 31 December 2001 who were eligible for BCG immunization. The Community Child Health computer was used to generate information about their BCG immunization status. RESULTS: 201 children were included in the study. One hundred and seventy-one children had received BCG immunization in the neonatal period, out of which 169 had received it before discharge from the hospital. Two children were immunized in the community in the neonatal period. Thus, 85% of the newborns eligible for BCG immunization received their vaccination in the neonatal period. CONCLUSIONS: The current "Neonatal BCG Immunisation Policy" is effective, and there is a high uptake of the vaccine in the neonatal period within the hospital itself. Newborn infants who do not receive BCG immunization in hospital rarely get immunized in the community.

Adjuvants, Immunologic↗

Historical introduction of acupuncture in India.

Acupuncture, though originated in oriental countries in the ancient times but, its philosophical understanding is amazingly wide open to the modern medical science. Historically, records are there regarding its Indian origin. However, acupuncture practised today in Indian sub-continent mainly shows Chinese origin and its introduction to India was pioneered by Dr. B.K. Basu, the first Indian who learned Chinese acupuncture from mainland China during 1959. It is interesting enough to note that though acupuncture is successfully practised in India in a rejuvenated form for the last few decades but due to lack of proper Governmental support this thereby suffers from under utilization and under development. While WHO suggested for its wider application and development through concerted Governmental efforts.

Acupuncture Therapy↗

Relationship between plasma Ara-C and intracellular Ara-CTP pools under conditions of continuous infusion and high-dose Ara-C treatment.

Plasma level Ara-C and Ara-U in vivo and intracellular Ara-CTP pools in vivo and in vitro were measured using high-performance liquid chromatography and radioimmunoassay. Plasma Ara-C during High Dose therapy was found in two phases; one, a peak at t1/2 of approximately 5-8 minutes, the other approaching that of Continuous Infusion with a t1/2 of about 6 to 8 hours. There appears to be no relationship between peak levels of plasma Ara-C and intracellular Ara-CTP formed during High Dose therapy. Intracellular Ara-CTP pools were found to be higher in peripheral blood than in bone marrow during High Dose treatment and were also higher in bone marrow of patients treated with High Dose rather than conventional dose Ara-C. In vitro experiments with various concentrations of Ara-C on patient cells prior to treatment suggest that patients may benefit from High Dose therapy when an increase in intracellular Ara-CTP occurred with higher extracellular concentrations of Ara-C. In patients with metabolically sensitive cells containing the necessary enzymes to activate Ara-C to Ara-CTP, where resistance is due to limited drug transport, High Dose therapy may prove beneficial. Conversely, in patients with no increase in Ara-CTP pools in vitro due to a depletion of activating enzymes, High Dose treatment may not be warranted. Therefore, it may be possible to determine patients most likely to benefit from High Dose chemotherapy by measuring pre-treatment in vitro intracellular Ara-CTP.

Arabinofuranosylcytosine Triphosphate↗